Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant

Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant Recipients Status 1-2. A Prospective Randomized Controlled Trial.

The purpose of the study is to examine if outcome after liver transplantation is improved by using albumin infusion post-transplantation.

Inclusion Criteria:

• 18 years or older
• Canadian Transplant status 1 or 2
• Patients at the Royal Victoria Hospital, Montreal, Canada

Exclusion Criteria:

• Emergency liver transplant (canadian transplant status 3 or 4)
• patients who have received more than 300cc of albumin within 48 hours prior to transplant
• patients who underwent previous solid organ transplant
• multi-organs transplant recipients
• patients who had previous adverse reaction to human albumin solution
• patients who have religious restriction to receiving human blood products.
• patients or surrogate unable to give consent to the study